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z Evidence summary
Data on the treatment of bipolar dis-
ease among fertile women are limited to 
case-control studies and drug registries 
because of a lack of RCTs in this popu-
lation.1 Onset of bipolar illness often 
occurs in the teens and twenties, which 
puts women with bipolar disorder at 
risk for having episodes requiring treat-
ment during their childbearing years. 
Treatment might be initiated for a non-
pregnant patient, but you must consider 
potential pregnancy when choosing a 
medication.
The TablE shows common medica-
tions used in bipolar illness, their risk cat-
egories for pregnancy and lactation, and 
monitoring recommendations.1–5
  
What’s the best strategy  
for bipolar disorder  
during pregnancy?
lithium	is	the	first-line	treatment	for	pregnant	
patients	requiring	medication	(sor:	C,	
based	on	expert	opinion).	
	 Monotherapy	is	preferred	for	women	of	
childbearing	age	who	have	bipolar	disorder	
(strength	of	recommendation	[sor]:	C,	
based	on	expert	opinion).	
	 When	prescribing	lithium	or	
anticonvulsant	drugs	(eg,	valproic	acid	and	
carbamazepine),	draw	blood	levels	monthly	
during	the	first	and	second	trimesters,	and	
then	weekly	in	the	third	trimester	(sor:	C,	
based	on	expert	opinion).	
	 give	all	pregnant	women	taking	
medications	for	the	prevention	of	mania	a	
detailed	fetal	anatomy	ultrasound	at	18	to	20	
weeks	(sor:	C,	based	on	expert	opinion).	
	 Behavior	therapy	has	a	role	as	an	
adjunct	to	pharmacologic	therapy,	but	no	
studies	show	its	benefit	alone	in	preventing	
mania	(sor:	C,	based	on	expert	opinion).
		 electroconvulsive	therapy	may	be	
beneficial	for	patients	with	refractory	
depressive	symptoms,	and	may	be	used	
in	pregnancy	(sor:	C,	based	on	expert	
opinion).	
Psychiatric consultation is essential
unfortunately,	the	medications	used	to	treat	
this	serious	health	problem	can	also	have	
important	negative	effects	on	a	patient’s	
health.	Although	the	principles	outlined	here	
are	helpful	guidelines,	in	practice	I	rarely	
treat	patients	with	bipolar	disorder	without	
psychiatric	consultation.	
	 As	family	physicians,	it’s	critical	that	
we	address	reliable	contraception	and	
the	importance	of	preconception	planning	
with	women	early	in	the	course	of	this	
psychiatric	illness.
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table
  PrEgnanCy laCTaTion  
  safETy  safETy 
TrEaTmEnT CaTEgory* CaTEgory† Dosing anD moniToring
lithium	 D	 l4	 More	frequent	dosing	maintains	therapeutic	levels	and	avoids	peaks;		
	 	 	 	 it’s	unclear	if	this	benefits	the	fetus		
	 	 	 	 Detailed	ultrasound	in	second	trimester	
	 	 	 	 Monthly	levels	during	1st	and	2nd,	weekly	during	3rd	trimester	
	 	 	 	 Decrease	dose	during	delivery,	up	to	50%	
anTiConvulsanTs
Carbamazepine (Tegretol)	 C/D	 l2	 Contraindicated	in	1st	trimester	
	 	 	 	 Monthly	levels	during	2nd	trimester,	weekly	during	3rd	trimester	
lamotrigine (lamictal)	 C	 l3		 Keep	daily	dose	under	200	mg	to	reduce	risk	of	congenital	anomalies
oxcarbazepine (Trileptal)	 C	 l3		 Decreases	level	of	oral	contraceptives
Topiramate (Topamax)	 C	 l3		 Decreases	level	of	oral	contraceptives
valproic acid (Depakene)	 D	 l2	 once-daily	dosing	may	cause	unpredictably	high	peak	levels	
	 	 	 	 Contraindicated	in	1st	trimester		
	 	 	 	 Monthly	levels	during	2nd	trimester,	weekly	during	3rd	trimester	
anTiPsyChoTiCs (TyPiCal anD aTyPiCal)
haloperidol (haldol)	 C	 l2		 First-generation	agents	recommended	in	1st	trimester	to	decrease		
Chlorpromazine (Thorazine)	 C	 l3	 risk	of	malformations	and	for	recurrence	of	symptoms	during		
	 	 	 	 pregnancy	among	unmedicated	patients
aripiprazole (abilify)	 C	 l3		
Clozapine (Clozaril)	 C/B	 l3		
olanzapine (Zyprexa)	 C	 l3		
Quetiapine (seroquel)	 C	 l4		
risperidone (risperdal)	 C	 l3		
Ziprasidone (geodon)	 C	 l4		 Does	not	decrease	effectiveness	of	oral	contraceptives
BEnZoDiaZEPinEs
alprazolam	 D	 l3	
	 	 	 	
Diazepam	 D	 l3/l4	for	 useful	for	regulating	sleep;	may	prevent	postpartum	relapse		
	 	 	 chronic	use	 of	mania
lorazepam 	 D		 l3		 High	potency	preferred	due	to	shorter	half-life
Clonazepam	 C/D	 l3	
CarDiovasCular or anTihyPErTEnsivE agEnTs
verapamil	 C	 l2		 efficacy	unproven	in	mania	of	bipolar	disorder	
	 	 	 	 Monitor	blood	pressure,	especially	if	normotensive
*Pregnancy risk categories:    † lactation risk categories from hale:4
a		safety	demonstrated	in	human	studies.	 	 	 l1		safest
B		safety	presumed	based	on	animal	studies.	 	 	 l2		safer
C			uncertain	safety	with	no	human	or	animal	studies		 	 l3		Moderately	safe
showing	adverse	effects.	 	 	 l4		Possibly	hazardous
D			unsafe;	evidence	of	risk	that	may	be	acceptable		 	 l5		Contraindicated	
in	certain	situations.
X		Highly	unsafe	and/or	a	teratogen.
Management of bipolar disorder during pregnancy: 
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Treat beyond  
delivery—and 
monitor the infant 
closely
lithium is first-line treatment 
Monotherapy for bipolar illness is pre-
ferred; it generally minimizes the risk 
of congenital anomalies. The use of 
lithium for long-term management of 
bipolar disorder is associated with de-
creased rates of suicide and all-cause 
mortality.6
is risk of Ebstein’s anomaly a factor? 
Lithium is associated with 10- to 20-fold 
higher risk of Ebstein’s anomaly, a con-
genital anomaly affecting the tricuspid 
valve and right ventricle, with varying 
clinical effects. However, the absolute 
risk is small: Ebstein’s anomaly occurs 
in 1:20,000 unexposed pregnancies.2,7,8 
Because concerns about this anomaly 
are less of a problem than once thought, 
lithium is the first-line treatment for bi-
polar disorder in pregnancy.7 
Discontinue with care. The risk of 
recurrence of mania is 3 times higher 
with rapid discontinuation of lithium 
over less than 2 weeks.2,7 Taper 
lithium over 2 to 4 weeks when discon-
tinuing the medication.7 
Women taking lithium may already 
be pregnant when you see them, and even 
a slow lithium taper may not minimize ex-
posure to the developing fetus.2,8 
Thoroughly discuss the risks and 
benefits of continued treatment and close 
monitoring compared with discontinua-
tion. 
anticonvulsants and antipsychotics 
pose their share of risks
antiseizure medications, including car-
bamazepine and valproic acid, are con-
sidered human teratogens in the first tri-
mester.9 If a woman has an unplanned 
pregnancy and presents late in the first 
trimester or in the second trimester, 
discontinuation of these medication 
in stable patients is not recommended. 
Valproate and carbamazepine are both 
compatible with breastfeeding. 
Although lamotrigine was thought 
to have fewer risks than other drugs, the 
FDA issued an alert in September 2006 
suggesting a possible increased risk of 
cleft palate for infants exposed to la-
motrigine in the first trimester.10 
Typical antipsychotics appear to be safe 
in pregnancy, but they can have side effects 
for the mother. These side effects include 
extrapyramidal symptoms, such as tardive 
dyskinesia and hyperprolactinemia. 
atypical antipsychotics have not been 
well studied, but there is no conclusive 
evidence that they cause fetal malforma-
tions.1
100-fold higher risk  
of postpartum psychosis
Women with bipolar disorder have a 
100-fold higher risk of developing post-
partum psychosis.2 
For this reason, treatment beyond de-
livery is recommended, along with close 
monitoring of the infant.  
Drug monitoring and dosing
second and third trimesters. Monitor the 
levels of lithium and anticonvulsants 
monthly through the second trimester, 
then weekly during the third trimester 
because of blood volume changes.2 
Medication doses may also need to 
be increased up to 50% during the sec-
ond and third trimesters, when creatinine 
clearance doubles and the plasma volume 
increases.8 
Postpartum. Following delivery, you’ll 
need to decrease the dose of lithium to 
prepregnancy doses, unless there is an 
acute destabilization of mood.2 
Verapamil for bipolar disorder? 
Wisner et al11 found verapamil to be ef-
fective for mania in a nonrandomized 
prospective study of bipolar hypomanic/
manic and depressed patients. 
Verapamil has been used for patients 
with hypertension during pregnancy, and 
studies that have looked at outcomes of 
pregnancies with exposure to verapamil 
showed no adverse drug related effects. 
Cognitive therapy may help
Cognitive behavior therapy—which 
focuses on adherence to treatment, 
bipolar disorder and pregnancy
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minimizing stressors, improving social 
and occupational function, and minimiz-
ing sleep deprivation—may help prevent 
mania, although there have been no 
studies specifically on prevention of ma-
nia using cognitive behavior therapy.1,2 
Is ECT teratogenic?
There have been no conclusive reports 
of teratogenicity with electroconvulsive 
therapy.2 
The most common complication, 
occurring in 1.5% of cases, were fetal 
arrhythmias.  Avoiding atropine, main-
taining oxygenation, avoiding exces-
sive hyperventilation, and elevating the 
right hip can decrease the risk of fetal 
arrhythmias during electroconvulsive 
therapy.5 
Recommendations from others 
Educate the mother and family on the 
impact of mental health and illness on 
a pregnant woman and the fetus, and 
the risks of medications during breast-
feeding. 
aPa Practice guideline. According to 
the American Psychiatric Association’s 
Practice Guideline for the Treatment of 
Patients with Bipolar Disorder:6 
 • Women with bipolar disorder 
should plan their pregnancies.
 • Physicians should encourage pa-
tients to use contraception and seek pre-
conception counseling. 
 • Because of genetic risks associated 
with bipolar disorder, patients may also 
benefit from genetic counseling.
 • High-potency antipsychotics are 
preferred during pregnancy because they 
are less likely to have associated anticho-
linergic, antihistaminergic, or hypoten-
sive effects.
Best Practices and Research in Clinical 
Obstetrics and Gynaecology from the UK 
suggests:12
 •  delaying conception until illness is 
in remission,
 •  discussing contraception, 
 •  coordinating with psychiatric con-
sultants before pregnancy, and
 •  reviewing teratogenic effects of 
medications with the patient.   n
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APA: High-potency  
antipsychotics are 
preferable during 
pregnancy; they're 
less likely to cause 
anticholinergic, 
antihistaminergic, 
or hypotensive  
effects
